Degradation kinetics of α‐conotoxin TxID

α‐Conotoxin (CTx) TxID is a potent α3β4 nicotinic acetylcholine receptor (nAChR) antagonist that has been suggested as a potential drug candidate to treat addiction and small cell lung cancer. The function and structure of TxID have been well‐studied, but analyses of its stability have not previousl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:FEBS Open Bio
Autors principals: Xu, Pan, Xiong, Yang, Liu, Yiqiao, Yu, Shurun, Zhangsun, Dongting, Wu, Yong, Luo, Sulan
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6722883/
https://ncbi.nlm.nih.gov/pubmed/31278882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/2211-5463.12697
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars